Grufity logoGrufity logo

BHC

7.93USD+0.23(+2.99%)Market Closed

Bausch Health Companies Inc.

Market Summary

USD7.93+0.23Market Closed
2.99%

BHC Stock Price

RSI Chart

Valuation

Market Cap

2.4B

Price/Earnings

55.44

Price/Sales

0.29

Price/Cashflow

3.68

MarketCap/EBT

91.68

Price/Sales

Profitability

EBT Margin

0.32%

Return on Equity

-177.2%

Return on Assets

0.15%

Fundamentals

Revenue

Revenue (TTM)

8.2B

Revenue Y/Y

-6.33%

Revenue Q/Q

2.55%

Earnings

Earnings (TTM)

43.0M

Earnings Y/Y

75.63%

Earnings Q/Q

-110.14%

Price Action

52 Week Range

28.35
(Low)(High)

Last 7 days

14.9%

Last 30 days

21.4%

Last 90 days

23.0%

Trailing 12 Months

-66.2%

Financial Health

Current Ratio

1.08

Debt/Equity

42.34

Debt/Cashflow

0.03

Investor Care

Dividend Yield

13.62%

Dividend/Share (TTM)

1.28

Shares Dilution (1Y)

0.81%

Diluted EPS (TTM)

0.13

Peers (Alternatives to Bausch Health Companies)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
459.8B
96.0B
5.64% 16.86%
24
4.79
5.02% 7.14%
342.0B
29.2B
5.87% 53.25%
60.08
11.76
5.34% 1.02%
266.2B
99.7B
9.09% -0.90%
9.08
2.63
43.92% 53.21%
255.3B
57.2B
10.70% 54.15%
15.4
4.47
35.88% 197.59%
163.4B
46.7B
4.75% 50.97%
24.47
3.5
2.79% 223.53%
MID-CAP
5.5B
4.4B
-19.59% -9.60%
-46.93
1.26
1.80% 57.67%
SMALL-CAP
1.9B
628.4M
27.93% -51.99%
-4.08
3.1
64.35% -18.14%
1.9B
659.0M
9.23% 20.30%
32.36
2.95
16.78% -53.92%
1.5B
-
32.82% -58.59%
-0.54
1.95
-4.11% -144.36%
1.2B
112.7M
16.50% -21.36%
-10.75
7.76
-54.94% 40.20%
1.1B
3.1M
16.81% -54.64%
-3.57
108.75
-77.09% -12.24%
1.0B
23.5M
9.62% 31.13%
-12.31
166.87
243.57% -1.04%
945.9M
373.2M
0.99% -19.37%
4.56
2.34
-0.39% -38.45%
283.2M
49.7M
-11.83% -51.92%
-8.71
5.67
28.95% 32.80%
68.8M
2.6B
-43.99% -88.43%
-0.03
0.02
-13.88% -4855.92%

Financials for Bausch Health Companies

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Revenue-1.6%8,1928,3258,4348,4518,478
  S&GA Expenses-0.3%2,6312,6402,6242,5802,499
Earnings Before Taxes105.0%26-515.00-1,024.00-1,439.00-1,580.00
Net Income110.6%43-407.00-948.00-1,170.00-1,287.00
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Assets-3.2%28,17129,09029,20229,25230,042
  Current Assets-7.2%5,4175,8365,6075,3245,450
    Cash Equivalents-47.2%6591,249582690642
  Inventory2.7%1,0731,0459931,0581,086
  Net PPE-2.2%1,5451,5791,5981,5841,590
  Goodwill-1.3%12,26612,42712,45712,47712,527
Liabilities-4.5%27,91829,23129,23629,38730,653
  Current Liabilities4.7%4,9974,7745,1985,4375,517
  Long Term Debt-5.8%21,81423,16822,65422,35823,439
    LT Debt, CurrentInfinity%150----
    LT Debt, Non Current-6.5%21,66423,16822,65422,35823,439
  Retained Earnings-1.6%-9,175.00-9,030.00-8,961.00-9,030.00-9,218.00
  Additional Paid-In Capital-74.9%104415462437413
Accumulated Depreciation-1,820----
Shares Outstanding0.1%362361359359359
Minority Interest1161.3%94675726976
Float-8,714----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q22022Q12021Q42021Q32021Q2
Cashflow From Operations-29.6%6489201,4261,7961,488
  Share Based Compensation-3.9%124129128119113
Cashflow From Investing-3.7%394409409405-253.00
Cashflow From Financing-30.2%-1,044.00-802.00-1,513.00-2,291.00-1,251.00

Risks

What is the probability of a big loss on BHC?

97.3%


Probability that Bausch Health Companies stock will be more than 20% underwater in next one year

72.7%


Probability that Bausch Health Companies stock will be more than 30% underwater in next one year.

33.9%


Probability that Bausch Health Companies stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does BHC drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Bausch Health Companies was unfortunately bought at previous high price.

Returns

Cumulative Returns on BHC

-17.9%


10-Year Cumulative Returns

-29.9%


7-Year Cumulative Returns

-14.4%


5-Year Cumulative Returns

-34.5%


3-Year Cumulative Returns

What are the long-term rolling returns for BHC?

FIve years rolling returns for Bausch Health Companies.

Which funds bought or sold BHC recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-22
IHT Wealth Management, LLC
-
-
-10,000
86,000
0.01%
2022-11-18
Legend Financial Advisors, Inc.
NEW
-
3,445
3,445
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-44,000
-
-%
2022-11-15
Pinz Capital Management, LP
NEW
-
441,000
441,000
0.80%
2022-11-15
Traynor Capital Management, Inc.
REDUCED
-7.08
-33,000
105,000
0.02%
2022-11-15
CONCOURSE FINANCIAL GROUP SECURITIES, INC.
SOLD OFF
-
-
-
-%
2022-11-15
BNP PARIBAS ARBITRAGE, SNC
REDUCED
-93.08
-2,000,000
121,023
-%
2022-11-15
SeaCrest Wealth Management, LLC
SOLD OFF
-100
-24,000
-
-%
2022-11-15
Balyasny Asset Management LLC
NEW
-
4,127,000
4,127,000
0.01%
2022-11-15
Truvestments Capital LLC
UNCHANGED
-
-1,000
1,000
-%

1–10 of 38

Latest Funds Activity

Are funds buying BHC calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own BHC

Bausch Health Companies News

Investing News Network

Bausch Health Wins DUOBRII and BRYHALI Patent Infringement Case.39 hours ago

BHC Fair Value

Recent SEC filings of Bausch Health Companies

View All Filings
Date Filed Form Type Document
Nov 30, 2022
8-K
Current Report
Nov 04, 2022
4
Insider Trading
Nov 03, 2022
10-Q
Quarterly Report
Nov 03, 2022
8-K
Current Report
Oct 04, 2022
8-K
Current Report
Oct 03, 2022
4
Insider Trading
Oct 03, 2022
4
Insider Trading
Oct 03, 2022
4
Insider Trading
Oct 03, 2022
4
Insider Trading
Oct 03, 2022
4
Insider Trading

Latest Insider Trading transactions for BHC

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-12-01
Carson Seana
SOLD FOR TAXES
-13,020.7
7.7
-1,691
EVP, General Counsel
2022-11-03
Carson Seana
SOLD FOR TAXES
-2,154.3
6.45
-334
EVP, General Counsel
2022-09-30
Paulson John
ACQUIRED
18,823.5
6.89
2,732
-
2022-09-30
WECHSLER AMY B
ACQUIRED
6,869.33
6.89
997
-
2022-09-30
ICAHN BRETT
ACQUIRED
30,619.2
6.89
4,444
-
2022-09-30
Paulson John
ACQUIRED
62,499.2
6.89
9,071
-
2022-09-30
ROBERTSON RUSSEL C
ACQUIRED
38,122.4
6.89
5,533
-
2022-09-30
DE SCHUTTER RICHARD U
ACQUIRED
34,374.2
6.89
4,989
-
2022-09-30
ROBERTSON RUSSEL C
ACQUIRED
34,374.2
6.89
4,989
-
2022-09-30
Miller Steven D
ACQUIRED
30,619.2
6.89
4,444
-

1–10 of 50

Robert N. Power
19100
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

BHC Income Statement

2022-09-30
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues    
Revenues$ 2,046$ 2,111$ 5,931$ 6,238
Expenses    
Selling, general and administrative6616531,9591,944
Research and development133121387348
Amortization of intangible assets2903389021,055
Goodwill impairments1190202469
Asset impairments, including loss on assets held for sale11815213
Restructuring, integration, separation and IPO costs1085829
Other expense (income), net4(183)6329
Total expenses1,8021,5375,2416,155
Operating income24457469083
Interest income3286
Interest expense(385)(351)(1,157)(1,083)
Gain (loss) on extinguishment of debt570(12)683(62)
Foreign exchange and other73411
Income (loss) before income taxes439216228(1,045)
(Provision for) benefit from income taxes(36)(25)(30)36
Net income (loss)403191198(1,009)
Net income attributable to noncontrolling interest(4)(3)(13)(8)
Net income (loss) attributable to Bausch Health Companies Inc.$ 399$ 188$ 185$ (1,017)
Earnings (loss) per share attributable to Bausch Health Companies Inc.    
Basic (in usd per share)$ 1.10$ 0.52$ 0.51$ (2.84)
Diluted (in usd per share)$ 1.10$ 0.52$ 0.51$ (2.84)
Weighted-average common shares    
Basic (in shares)362.5359.6361.8358.5
Diluted (in shares)363.4364.0363.7358.5
Product sales    
Revenues    
Revenues$ 2,026$ 2,088$ 5,871$ 6,167
Expenses    
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues5785741,6911,742
Other revenues    
Revenues    
Revenues20236071
Expenses    
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues$ 6$ 8$ 21$ 26

BHC Balance Sheet

2022-09-30
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 486$ 582
Restricted cash and other settlement deposits111,537
Trade receivables, net1,7391,775
Inventories, net1,056993
Prepaid expenses and other current assets718720
Total current assets4,0105,607
Property, plant and equipment, net1,5071,598
Intangible assets, net6,0246,948
Goodwill12,04412,457
Deferred tax assets, net2,3722,252
Other non-current assets341340
Total assets26,29829,202
Current liabilities:  
Accounts payable486407
Accrued and other current liabilities2,9344,791
Current portion of long-term debt4110
Total current liabilities3,8315,198
Acquisition-related contingent consideration189202
Non-current portion of long-term debt20,80422,654
Deferred tax liabilities, net422529
Other non-current liabilities619653
Total liabilities25,86529,236
Commitments and contingencies (Note 18)
Equity (Deficit)  
Common shares, no par value, unlimited shares authorized, 361,781,292 and 359,405,748 issued and outstanding at September 30, 2022 and December 31, 2021, respectively10,38710,317
Additional paid-in capital129462
Accumulated deficit(8,776)(8,961)
Accumulated other comprehensive loss(2,265)(1,924)
Total Bausch Health Companies Inc. shareholders’ deficit(525)(106)
Noncontrolling interest95872
Total equity (deficit)433(34)
Total liabilities and equity (deficit)$ 26,298$ 29,202